Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Hereditary Hemorrhagic Telangiectasia

Treatments: Other: Counseling

Study type: Interventional

Funder types: Other

Identifiers

NCT05752253

3136

Details and patient eligibility

About

The goal of this interventional study is to determine the incidence of depression, anxiety, sleep disturbances and resilience in a sample of subjects affected by Hereditary Hemorrhagic Telangiectasia. The study is declined through the evaluation of some outcome parameters at the time of enrollment (T0), during the counseling intervention (T1 and T2) and at the end (T3) of the subjects who will have carried out an individual counseling intervention.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Recruited subjects have a diagnosis of Hereditary Hemorrhagic Telangiectasia and are 18 years of age or older.

Exclusion criteria

Previous or current intellectual disability and a diagnosis of psychiatric disorders in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5.

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Patients with Hereditary Hemorragic Teleangectasia

Other group

Description:

Patients with Hereditary Hemorragic Teleangectasia

Treatment:

Other: Counseling